{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:16:16Z","timestamp":1792088176854,"version":"4.4.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jaip.2024.04.034","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T11:46:07Z","timestamp":1714218367000},"page":"1415-1427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis\/Conjunctivitis and Asthma"],"prefix":"10.1016","volume":"12","author":[{"given":"Peter Socrates","family":"Creticos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma E.","family":"Gunaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Damask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.04.034_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1258\/jrsm.2012.12k044","article-title":"The origins of inoculation","volume":"105","author":"Boylston","year":"2012","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.jaip.2024.04.034_bib2","unstructured":"Immunisation Advisory Centre \u2013 Immune.org.nz (Univ of Auckland). A brief history of vaccination. Accessed May 14, 2024. https:\/\/www.immune.org.nz\/vaccines\/vaccine-development"},{"key":"10.1016\/j.jaip.2024.04.034_bib3","unstructured":"National Library of Medicine (NIH). History of medicine: Smallpox: A great and terrible scourge. Accessed May 14, 2024. https:\/\/www.nlm.nih.gov\/exhibition\/smallpox\/index.html"},{"key":"10.1016\/j.jaip.2024.04.034_bib4","unstructured":"Jenner E. An inquiry into the causes and effects of the variolae vaccinae, or cowpox. The Harvard Classics; 1798:1909-14."},{"key":"10.1016\/j.jaip.2024.04.034_bib5","series-title":"Experimental Researches on the Causes and Nature of Catarrhus aestivus","author":"Blackley","year":"1873"},{"key":"10.1016\/j.jaip.2024.04.034_bib6","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)78276-6","article-title":"Prophylactic inoculation against hay fever","volume":"177","author":"Noon","year":"1911","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.04.034_bib7","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0140-6736(01)40417-X","article-title":"Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine","volume":"178","author":"Freeman","year":"1911","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.04.034_bib8","first-page":"1156","article-title":"The oral administration of pollen","volume":"12","author":"Black","year":"1927","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jaip.2024.04.034_bib9","first-page":"11","article-title":"A\u00a0review of oral specific immunotherapy","volume":"1","author":"Creticos","year":"1995","journal-title":"Expressions"},{"key":"10.1016\/j.jaip.2024.04.034_bib10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/all.14113","volume":"75","author":"Passalacqua","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2500\/aap.2007.28.2919","article-title":"Mucosal immunization application to allergic disease: sublingual immunotherapy","volume":"28","author":"Frati","year":"2007","journal-title":"Allergy asthma Proc"},{"key":"10.1016\/j.jaip.2024.04.034_bib12","doi-asserted-by":"crossref","first-page":"e2249980","DOI":"10.1002\/eji.202249980","article-title":"Tissue-specific antigen-presenting cells contribute to distinct phenotypes of allergy","volume":"53","author":"Schulke","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib13","series-title":"UpToDate","article-title":"Subcutaneous immunotherapy (SCIT) for allergic disease: Indications and efficacy","author":"Creticos","year":"2019"},{"key":"10.1016\/j.jaip.2024.04.034_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nri1934","article-title":"Immunological mechanisms of allergen-specific immunotherapy","volume":"6","author":"Larch\u00e9","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib15","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","article-title":"Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers","volume":"140","author":"Shamji","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41577-022-00786-1","article-title":"Allergen immunotherapy: past, present and future","volume":"23","author":"Durham","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaci.2005.03.011","article-title":"IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy","volume":"116","author":"Nouri-Aria","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0091-6749(91)90297-2","article-title":"Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity","volume":"88","author":"Furin","year":"1991","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib19","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1046\/j.1365-2222.2001.01231.x","article-title":"Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium","volume":"31","author":"Wilson","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib20","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1067\/mai.2001.115483","article-title":"Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season","volume":"107","author":"Wilson","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jaci.2014.07.029","article-title":"Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy","volume":"134","author":"Lao-Araya","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.immuni.2020.12.013","article-title":"Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response","volume":"54","author":"Golebski","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2024.04.034_bib23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaci.2015.09.015","article-title":"Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy","volume":"137","author":"Gueguen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib24","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2012.02.014","article-title":"A\u00a0regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy","volume":"129","author":"Zimmer","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jaci.2011.08.034","article-title":"Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy","volume":"129","author":"Wambre","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib26","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jaci.2017.09.041","article-title":"Synchronous immune alterations mirror clinical response during allergen immunotherapy","volume":"141","author":"Renand","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib27","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1067\/mai.2003.1570","article-title":"Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy","volume":"111","author":"Francis","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jaci.2007.06.013","article-title":"Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation","volume":"120","author":"Bohle","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1164\/rccm.200905-0686OC","article-title":"House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells","volume":"180","author":"O\u2019Hehir","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.04.034_bib30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jaci.2018.06.041","article-title":"Role of IL-35 in sublingual allergen immunotherapy","volume":"143","author":"Shamji","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0091-6749(97)70106-4","article-title":"Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy","volume":"99","author":"Hamid","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib32","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1111\/j.1399-3038.2009.00920.x","article-title":"Clinical outcome and IL-17, IL-23, IL-27 and FOXP3 expression in peripheral blood mononuclear cells of pollen-allergic children during sublingual immunotherapy","volume":"21","author":"Nieminen","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib33","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0091-6749(96)70205-1","article-title":"Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma","volume":"97","author":"Durham","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib34","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.4049\/jimmunol.172.5.3252","article-title":"Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity","volume":"172","author":"Nouri-Aria","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib35","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.4049\/jimmunol.178.7.4658","article-title":"Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression","volume":"178","author":"Pilette","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib36","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jaci.2020.10.035","article-title":"Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy","volume":"147","author":"Sharif","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib37","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jaci.2018.10.061","article-title":"Role of Der p 1-specific B cells in immune tolerance during 2 years of house dust mite-specific immunotherapy","volume":"143","author":"Boonpiyathad","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib38","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1111\/all.14908","article-title":"The role of allergen-specific IgE, IgG and IgA in allergic disease","volume":"76","author":"Shamji","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1398-9995.2011.02745.x","article-title":"Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy","volume":"67","author":"Shamji","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib40","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaci.2021.03.030","article-title":"Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy","volume":"148","author":"Shamji","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib41","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(54)91620-7","article-title":"Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass pollen extracts with the isolated main protein component","volume":"266","author":"Frankland","year":"1954","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.04.034_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000228145","article-title":"Seasonal hay fever and asthma treated with pollen extracts","volume":"6","author":"Frankland","year":"1955","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib43","first-page":"165","article-title":"A\u00a0double blind study of treatment with aqueous allergenic extracts in cases of allergic rhinitis","volume":"34","author":"Lowell","year":"1963","journal-title":"J\u00a0Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM196509232731302","article-title":"A\u00a0double-blind study of the effectiveness and specificity of injection therapy in ragweed hay fever","volume":"273","author":"Lowell","year":"1965","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.04.034_bib45","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1021\/bi00910a027","article-title":"Isolation studies of allergens from ragweed pollen","volume":"1","author":"King","year":"1962","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaip.2024.04.034_bib46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaci.2007.02.035","article-title":"Legends in allergy: PS Norman and LM Lichtenstein \u2013 The Hopkins Experience","volume":"119","author":"Creticos","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib47","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2500\/aap.2022.43.220033","article-title":"Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease","volume":"43","author":"Creticos","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.04.034_bib48","first-page":"93","article-title":"Immunotherapy of hay fever with ragweed antigen E: comparisons with whole pollen extract and placebos","volume":"42","author":"Norman","year":"1968","journal-title":"J\u00a0Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-75-5-663","article-title":"A\u00a0single year of immunotherapy for ragweed hay fever: immunologic and clinical studies","volume":"75","author":"Lichtenstein","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2024.04.034_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0091-6749(71)80005-2","article-title":"Maintenance immunotherapy in ragweed hay fever: booster injections at six week intervals","volume":"47","author":"Norman","year":"1971","journal-title":"J\u00a0Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0091-6749(78)90116-1","article-title":"The clinical and immunologic specificity of immunotherapy","volume":"61","author":"Norman","year":"1978","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib52","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0091-6749(80)90012-3","article-title":"A\u00a0comparative study of the effectiveness of the Rinkel method and the current standard method of immunotherapy for ragweed pollen hay fever","volume":"66","author":"Van Metre","year":"1980","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0091-6749(84)90490-1","article-title":"Dose response of IgE and IgG antibodies during ragweed immunotherapy","volume":"73","author":"Creticos","year":"1984","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib54","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1172\/JCI112233","article-title":"Nasal challenge with ragweed pollen in hay fever patients: effect of immunotherapy","volume":"76","author":"Creticos","year":"1985","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2024.04.034_bib55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0091-6749(89)90325-4","article-title":"Responses to ragweed-pollen nasal challenge before and after immunotherapy","volume":"84","author":"Creticos","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib56","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.04.034_bib57","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jama.2016.21040","article-title":"Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal allergic rhinitis: the GRASS randomized clinical trial","volume":"317","author":"Scadding","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.04.034_bib58","first-page":"CD001186","article-title":"Allergen immunotherapy for asthma","volume":"4","author":"Abramson","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2024.04.034_bib59","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/all.13208","article-title":"Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib60","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2217\/imt-2018-0087","article-title":"Efficacy and tolerability of a house dust mite allergoid in allergic bronchial asthma: a randomized dose-ranging trial","volume":"10","author":"Jutel","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaip.2024.04.034_bib61","doi-asserted-by":"crossref","first-page":"100098","DOI":"10.1016\/j.waojou.2020.100098","article-title":"Subcutaneous allergen immunotherapy for asthma: a randomized, double-blind, placebo-controlled study with a standardized Blomia tropicalis vaccine","volume":"13","author":"Castro-Almarales","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2024.04.034_bib62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.19070\/2332-2799-2200014","article-title":"Evaluation of subcutaneous immunotherapy in asthmatics to Dermatophagoides siboney and Dermatophagoides pteronyssinus","volume":"7","author":"Castro-Almarales","year":"2022","journal-title":"Int J Clin Med Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib63","doi-asserted-by":"crossref","first-page":"100275","DOI":"10.1016\/j.lanepe.2021.100275","article-title":"Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: results from the REACT study, a retrospective cohort study","volume":"13","author":"Fritzsching","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jaip.2024.04.034_bib64","doi-asserted-by":"crossref","first-page":"2200446","DOI":"10.1183\/13993003.00446-2022","article-title":"Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study","volume":"60","author":"Woehlk","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2024.04.034_bib65","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jaci.2017.07.025","article-title":"Viral infections in allergy and immunology: how allergic inflammation influences viral infections and illness","volume":"140","author":"Edwards","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib66","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.202209-1708OC","article-title":"Allergen immunotherapy enhances airway epithelial antiviral immunity in patients with allergic asthma (VITAL study): a double-blind randomized controlled trial","volume":"207","author":"Woehlk","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2024.04.034_bib67","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","article-title":"Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis","volume":"118","author":"Dahl","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib68","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","article-title":"Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis","volume":"117","author":"Durham","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib69","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2010.11.035","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults","volume":"127","author":"Nelson","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib71","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2010.11.034","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents","volume":"127","author":"Blaiss","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib72","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anai.2013.11.018","article-title":"Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial","volume":"112","author":"Maloney","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib73","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2013.03.019","article-title":"Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults","volume":"131","author":"Creticos","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib74","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anai.2014.04.018","article-title":"Safety and tolerability of a short ragweed sublingual immunotherapy tablet","volume":"113","author":"Nolte","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib75","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaci.2012.08.032","article-title":"Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE","volume":"130","author":"Cox","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib76","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2016.06.044","article-title":"Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial","volume":"138","author":"Nolte","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib77","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jaci.2016.09.043","article-title":"Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis","volume":"139","author":"Okubo","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib78","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/all.12996","article-title":"House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis","volume":"72","author":"Okamoto","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib79","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaip.2018.11.044","article-title":"Long-term efficacy and dose-finding trial of Japanese cedar pollen sublingual immunotherapy tablet","volume":"7","author":"Gotoh","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib80","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.jaip.2021.01.035","article-title":"Treatment effect of the tree pollen SLIT-tablet on allergic rhinoconjunctivitis during oak pollen season","volume":"9","author":"Nolte","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib81","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/all.13201","article-title":"Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib82","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jaci.2018.12.1001","article-title":"The SQ tree SLIT-tablet is highly effective and well tolerated: results from a randomized, double-blind, placebo-controlled phase III trial","volume":"143","author":"Biedermann","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib83","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.jaip.2020.03.041","article-title":"Efficacy and safety of ragweed SLIT-tablet in children with allergic rhinoconjunctivitis in a randomized, placebo-controlled trial","volume":"8","author":"Nolte","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib84","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/j.jaip.2021.06.060","article-title":"Disease-modifying effect of Japanese cedar pollen sublingual immunotherapy tablets","volume":"9","author":"Yonekura","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib85","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/pai.12984","article-title":"Efficacy of house dust mite sublingual tablet in the treatment of allergic rhinoconjunctivitis: a randomized trial in a pediatric population","volume":"30","author":"Okamoto","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib86","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1111\/all.13544","article-title":"Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet in Japanese children","volume":"73","author":"Masuyama","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib87","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2020.07.036","article-title":"A\u00a0300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized phase III clinical trial","volume":"147","author":"Demoly","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib88","series-title":"Allergenic Products Advisory Committee (APAC) meeting","year":"2013"},{"key":"10.1016\/j.jaip.2024.04.034_bib89","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib90","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13601-015-0057-8","article-title":"Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score","volume":"5","author":"Didier","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib92","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaci.2017.06.014","article-title":"Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy","volume":"141","author":"Valovirta","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib93","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib94","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/all.13317","article-title":"EAACI Guidelines on Allergen Immunotherapy: allergic rhinoconjunctivitis","volume":"73","author":"Roberts","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib95","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaci.2014.03.019","article-title":"Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial","volume":"134","author":"Mosbech","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib96","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jaci.2014.12.1911","article-title":"Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber","volume":"135","author":"Nolte","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib97","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.04.034_bib98","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jaip.2019.09.002","article-title":"Efficacy and safety of HDM SLIT tablet in Japanese adults with allergic asthma","volume":"8","author":"Tanaka","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/all.12560","article-title":"Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma","volume":"70","author":"Maloney","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib101","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1398-9995.2003.00387.x","article-title":"Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study","volume":"59","author":"Khinchi","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib102","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaci.2012.08.012","article-title":"Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison","volume":"130","author":"Di Bona","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib103","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaip.2014.09.018","article-title":"Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy","volume":"3","author":"Nelson","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib104","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.iac.2021.09.012","article-title":"Systemic allergic reactions and anaphylaxis associated with allergen immunotherapy","volume":"42","author":"Dhamija","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.04.034_bib105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaip.2023.11.011","article-title":"Anaphylaxis in clinical trials of sublingual immunotherapy tablets","volume":"12","author":"Nolte","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib106","doi-asserted-by":"crossref","first-page":"AB173","DOI":"10.1016\/j.jaci.2020.12.610","article-title":"The 12-SQ HDM SLIT-tablet shows similar safety and efficacy across geographies, ethnic and age groups","volume":"147","author":"Nolte","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib107","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.jaci.2017.09.051","article-title":"Effect of grass sublingual tablet immunotherapy is similar in children and adults: a Bayesian approach to design pediatric sublingual immunotherapy trials","volume":"141","author":"Kaur","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib108","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/pai.12747","article-title":"Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents","volume":"28","author":"Matsuoka","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib109","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.anai.2016.12.009","article-title":"Sublingual immunotherapy: a focused allergen immunotherapy practice parameter update","volume":"118","author":"Greenhawt","year":"2017","journal-title":"Ann Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaip.2023.06.036","article-title":"The art of dosing for subcutaneous immunotherapy in North America","volume":"12","author":"Nelson","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib111","doi-asserted-by":"crossref","first-page":"100766","DOI":"10.1016\/j.waojou.2023.100766","article-title":"Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: similarities and differences 2023","volume":"16","author":"Pfaar","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2024.04.034_bib112","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/alr.21561","article-title":"Dosing of sublingual immunotherapy for allergic rhinitis: evidence-based review with recommendations","volume":"5","author":"Leatherman","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2024.04.034_bib113","series-title":"Compassionate Use Programmes in Europe","author":"Bouygues","year":"2017"},{"key":"10.1016\/j.jaip.2024.04.034_bib114","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5414\/ALX02450E","article-title":"DGAKI and PEI in dialogue 2023: diagnostics and allergen immunotherapy","volume":"7","author":"Pfaar","year":"2023","journal-title":"Allergol Select"},{"key":"10.1016\/j.jaip.2024.04.034_bib115","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1016\/j.jaip.2021.08.018","article-title":"Efficacy of subcutaneous and sublingual immunotherapy for house dust mite allergy: a network meta-analysis-based comparison","volume":"9","author":"Kim","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib116","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1399-3038.2011.01219.x","article-title":"Sublingual immunotherapy not effective in house dust mite-allergic children in primary care","volume":"23","author":"de Bot","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib117","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaci.2010.09.017","article-title":"The Consolidated Standards of Reporting Trials (CONSORT) statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article","volume":"127","author":"Bousquet","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib118","unstructured":"US Food and Drug Administration, CBER. Vaccines, blood, and biologics: allergenics (Allergen Extracts): Massie E. Statistical Review (Oralair) 4\/7\/2014 Completed 2\/12\/2014. Accessed May 14, 2024. https:\/\/www.fda.gov\/vaccines-blood-biologics\/allergenics\/oralair"},{"key":"10.1016\/j.jaip.2024.04.034_bib119","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2009.07.054","article-title":"Recommendations for appropriate sublingual immunotherapy clinical trials","volume":"124","author":"Casale","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib120","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jaci.2012.06.047","article-title":"High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study","volume":"130","author":"Wahn","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib121","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaci.2013.10.041","article-title":"Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis","volume":"133","author":"Creticos","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib122","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-7022-4-7","article-title":"Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study","volume":"4","author":"Worm","year":"2014","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib123","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2018.11.018","article-title":"Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma","volume":"143","author":"Pfaar","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib124","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1939-4551-7-6","article-title":"Sublingual immunotherapy: World Allergy Organization position paper 2013 update","volume":"7","author":"Canonica","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2024.04.034_bib125","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s40629-014-0032-2","volume":"23","author":"Pfaar","year":"2014","journal-title":"Allergo J Int"},{"key":"10.1016\/j.jaip.2024.04.034_bib126","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5414\/ALX02120E","article-title":"ARIA guideline 2019: treatment of allergic rhinitis in the German health system","volume":"3","author":"Klimek","year":"2019","journal-title":"Allergol Select"},{"key":"10.1016\/j.jaip.2024.04.034_bib127","series-title":"Global Strategy for Asthma Management and Prevention","year":"2020"},{"key":"10.1016\/j.jaip.2024.04.034_bib128","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1542\/peds.2013-0343","article-title":"Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review","volume":"131","author":"Kim","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2024.04.034_bib129","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaci.2010.06.013","article-title":"Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis","volume":"126","author":"Di Bona","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib130","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2013.2049","article-title":"Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review","volume":"309","author":"Lin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.04.034_bib131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/alr.23090","article-title":"International consensus statement on allergy and rhinology: allergic rhinitis - 2023","volume":"13","author":"Wise","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2024.04.034_bib132","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1081-1206(10)62726-3","article-title":"Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study","volume":"82","author":"Mungan","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib133","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1081-1206(10)60475-9","article-title":"Economic evaluation of sublingual vs subcutaneous allergen immunotherapy","volume":"100","author":"Pokladnikova","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib134","first-page":"119","article-title":"Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study","volume":"39","author":"Mauro","year":"2007","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib135","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/039463200902200217","article-title":"Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy","volume":"22","author":"Ventura","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaip.2024.04.034_bib136","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000327566","article-title":"Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study","volume":"157","author":"Yukselen","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib137","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000124286","article-title":"Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis","volume":"70","author":"Tahamiler","year":"2008","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.jaip.2024.04.034_bib138","first-page":"461","article-title":"Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus","volume":"71","author":"Piazza","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib139","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1365-2222.2009.03448.x","article-title":"Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic\/rhinitis children sensitized to house dust mite: an open randomized controlled trial","volume":"40","author":"Eifan","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s40521-023-00338-5","article-title":"Allergy immunotherapy: state of the art","volume":"10","author":"Nelson","year":"2023","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib141","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/alr.23078","article-title":"Systematic review of real-world persistence and adherence in subcutaneous allergen immunotherapy","volume":"13","author":"Park","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2024.04.034_bib142","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jaip.2019.01.058","article-title":"AAAAI\/ACAAI Subcutaneous Surveillance Study (2013-2017): fatalities, infections, delayed reactions, and use of epinephrine autoinjectors","volume":"7","author":"Epstein","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib143","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.anai.2016.02.001","article-title":"Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: national surveillance study on allergen immunotherapy (2008-2013)","volume":"116","author":"Epstein","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib144","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anai.2021.03.011","article-title":"Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthma","volume":"127","author":"Epstein","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib145","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2500\/aap.2022.43.220035","article-title":"Safety of subcutaneous allergen immunotherapy","volume":"43","author":"Bernstein","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.04.034_bib146","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaip.2016.09.017","article-title":"Current evidence on safety and practical considerations for administration of sublingual allergen immunotherapy (SLIT) in the United States","volume":"5","author":"Epstein","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib147","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.anai.2016.07.024","article-title":"Efficacy of sublingual immunotherapy for cedar pollinosis: a systematic review and meta-analysis","volume":"117","author":"Yang","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib148","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jaip.2020.01.008","article-title":"Safety of timothy grass sublingual immunotherapy tablet in children: pooled analyses of clinical trials","volume":"8","author":"Halken","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib149","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.anai.2023.03.006","article-title":"House dust mite sublingual immunotherapy tablet safety in adolescents with allergic rhinoconjunctivitis: worldwide clinical trial results","volume":"130","author":"Horn","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib150","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/00325481.2017.1302306","article-title":"A\u00a0practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice","volume":"129","author":"Bernstein","year":"2017","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jaip.2024.04.034_bib151","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaip.2016.06.020","article-title":"Local side effects of sublingual and oral immunotherapy","volume":"5","author":"Passalacqua","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib152","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2500\/aap.2022.43.220017","article-title":"Allergen immunotherapy and shared decision-making","volume":"43","author":"Settipane","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.04.034_bib153","author":"Creticos"},{"key":"10.1016\/j.jaip.2024.04.034_bib154","unstructured":"U.S. Food and Drug Administration. Injectable allergen extracts - standardized. Accessed November 1, 2023. https:\/\/www.fda.gov\/vaccines-blood-biologics\/allergenics\/injectable-allergen-extracts-standardized"},{"key":"10.1016\/j.jaip.2024.04.034_bib155","unstructured":"U.S. Food and Drug Administration. Injectable allergen extracts - nonstandardized. Accessed November 1, 2023. https:\/\/www.fda.gov\/vaccines-blood-biologics\/allergenics\/injectable-allergen-extracts-non-standardized"},{"key":"10.1016\/j.jaip.2024.04.034_bib156","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jaci.2019.01.024","article-title":"Understanding differences in allergen immunotherapy products and practices in North America and Europe","volume":"143","author":"Mahler","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib157","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0091-6749(96)70162-8","article-title":"Studies of allergen extract stability: the effects of diluting and mixing","volume":"98","author":"Nelson","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib158","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1001\/jama.1992.03490200086009","article-title":"Immunotherapy with allergens","volume":"258","author":"Creticos","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.04.034_bib159","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1067\/mai.2003.41","article-title":"A\u00a0double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract","volume":"111","author":"Ewbank","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaip.2023.10.039","article-title":"The art of immunotherapy","volume":"12","author":"Nelson","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.04.034_bib161","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1365-2222.2008.03060.x","article-title":"Sublingual immunotherapy in youngsters: adherence in a clinical trial","volume":"38","author":"Roder","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib162","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2500\/aap.2022.43.210120","article-title":"Long-term strategies for allergen immunotherapy","volume":"43","author":"Larenas-Linnemann","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.04.034_bib163","author":"Creticos"},{"key":"10.1016\/j.jaip.2024.04.034_bib164","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1398-9995.2009.02223.x","article-title":"Sublingual immunotherapy: adherence based on timing and monitoring control visits","volume":"65","author":"Vita","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib165","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1399-3038.2012.01317.x","article-title":"Adherence to sublingual immunotherapy in preschool children","volume":"23","author":"Pajno","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib166","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/alr.21037","article-title":"A\u00a0comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy","volume":"2","author":"Hsu","year":"2012","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2024.04.034_bib167","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/alr.21909","article-title":"Nonadherence to sublingual immunotherapy in allergic rhinitis: a real-life analysis","volume":"7","author":"Wang","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2024.04.034_bib168","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41533-018-0072-z","article-title":"Adherence and quality of life in adults and children during 3-years of SLIT treatment with Grazax\u2014a real life study","volume":"28","author":"Kiotseridis","year":"2018","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaip.2024.04.034_bib169","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaci.2010.06.045","article-title":"How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers\u2019 viewpoint","volume":"126","author":"Senna","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib170","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2013.03.013","article-title":"Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy","volume":"132","author":"Kiel","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib171","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2147\/PPA.S70326","article-title":"Patients\u2019 compliance with different administration routes for allergen immunotherapy in Germany","volume":"8","author":"Egert-Schmidt","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jaip.2024.04.034_bib172","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/PPA.S122948","article-title":"Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center","volume":"11","author":"Lemberg","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jaip.2024.04.034_bib173","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.jaci.2017.12.999","article-title":"Comparison of allergy medication persistence with a sublingual immunotherapy tablet versus subcutaneous immunotherapy in Germany","volume":"141","author":"Allam","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib174","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2147\/PPA.S242957","article-title":"Real-world adherence and evidence of subcutaneous and sublingual immunotherapy in grass and tree pollen-induced allergic rhinitis and asthma","volume":"14","author":"Vogelberg","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jaip.2024.04.034_bib175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12948-018-0093-8","article-title":"Sublingual grass allergen specific immunotherapy: a retrospective study of clinical outcome and discontinuation","volume":"16","author":"Janson","year":"2018","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.jaip.2024.04.034_bib176","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2500\/aap.2024.45.230068","article-title":"Sublingual immunotherapy tablets in monosensitized and polysensitized adults with allergic rhinoconjunctivitis","volume":"45","author":"Nelson","year":"2024","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.04.034_bib177","first-page":"301","article-title":"Sequential treatment initiation with Timothy grass and ragweed sublingual immunotherapy tablets followed by simultaneous treatment is well tolerated","volume":"4","author":"Maloney","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib178","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jaci.2019.01.032","article-title":"Mind the gaps: clinical trial concepts to address unanswered questions in aeroallergen immunotherapy\u2014an NIAID\/AHRQ workshop","volume":"143","author":"Wheatley","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.04.034_bib179","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaip.2022.10.036","article-title":"Dose adjustment after gaps in administration of subcutaneous immunotherapy from a past survey: work group report of the AAAAI Allergen Standardization and Allergy Diagnostics Committee","volume":"11","author":"Larenas-Linnemann","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824004197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824004197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T17:53:00Z","timestamp":1738777980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824004197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":178,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2213219824004197"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.04.034","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis\/Conjunctivitis and Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}